Power Law company profile

Santhera Pharmaceuticals

Biotech & Life Sciences · Pratteln, Switzerland · Founded 2004 · IPO 2006 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$260M

Market cap · Apr/2026

Revenue

$71M

Latest reported FY

Investors

3 investors on Santhera Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Series B+ 2 investors entered at this stage

Global footprint

Web traffic by country

10K monthly visits
across markets

🇬🇧 United Kingdom59%

🇨🇭 Switzerland20%

🇺🇸 United States18%

🇮🇳 India6%

Top 4 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo